Daniele Cavaleri

Dr. Daniele Cavaleri

School of Medicine and Surgery, University of Milano-Bicocca, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2020 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
FBFrancesco Bartoli
Francesco Bartoli
Blazej MisiakBlazej Misiak
Blazej Misiak
TCTommaso Callovini
Tommaso Callovini
Daniele CavaleriDaniele Cavaleri
Daniele Cavaleri
RCRiccardo Matteo Cioni
Riccardo Matteo Cioni
GCGiuseppe Carrà
Giuseppe Carrà

1 December 2021 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Open access
Blazej MisiakBlazej Misiak
Blazej Misiak
BSBartłomiej Stańczykiewicz
Bartłomiej Stańczykiewicz
MWMichał Wiśniewski
Michał Wiśniewski
FBFrancesco Bartoli
Francesco Bartoli
GCGiuseppe Carrà
Giuseppe Carrà
DFDorota Frydecka
Dorota Frydecka
There is accumulating evidence that individuals with schizophrenia show altered levels of thyroid hormones. However, a qualitative and quantitative synthesis of findings in this field has not been performed so far. Therefore, we aimed to perform a systematic review and meta-analysis of studies investigating the levels of thyroid-stimulating hormone (TSH), free thyroxine (fT4), total thyroxine (tT4), free triiodothyronine (fT3) and total triiodothyronine (tT3) in multiple-episode schizophrenia (MES) and first-episode psychosis (FEP). Electronic databases were searched from their inception until 30th May 2020 by two independent reviewers. Random-effects meta-analyses and meta-regression analyses were performed. Altogether, 19 studies were included. Persons with FEP had significantly lower TSH levels (5 studies, g = -0.26, 95%CI: -0.47 to -0.06, p = 0.013, I2 = 21.3%), higher fT4 levels (3 studies, g = 0.58, 95%CI: 0.15-1.01, p = 0.008, I2 = 64.6%) and lower tT3 levels (2 studies, g = -0.60, 95%CI: -0.82 to -0.37, p < 0.001, I2 = 0%) compared to controls. Elevated TSH levels were found in persons with MES (13 studies, g = 0.20, 95%CI: 0.02-0.39, p = 0.031, I2 = 50.0%). Our findings imply that the levels of TSH might be decreased in persons with FEP and increased in those with MES. Other alterations need to be confirmed by additional studies. These findings imply the need to monitor the levels of TSH and thyroid hormones from the onset of psychosis.

13 October 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
Cristina CrocamoCristina Crocamo
Cristina Crocamo
BBBianca Bachi
Bianca Bachi
ACAngela Calabrese
Angela Calabrese
TCTommaso Callovini
Tommaso Callovini
Daniele CavaleriDaniele Cavaleri
Daniele Cavaleri
GCGiuseppe Carrà
Giuseppe Carrà

1 November 2021 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
FBFrancesco Bartoli
Francesco Bartoli
Daniele CavaleriDaniele Cavaleri
Daniele Cavaleri
BBBianca Bachi
Bianca Bachi
FMFederico Moretti
Federico Moretti
IRIlaria Riboldi
Ilaria Riboldi
GCGiuseppe Carrà
Giuseppe Carrà

9 September 2022 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
Daniele CavaleriDaniele Cavaleri
Daniele Cavaleri
FBFrancesco Bartoli
Francesco Bartoli
CCChiara Alessandra Capogrosso
Chiara Alessandra Capogrosso
PGPierluca Guzzi
Pierluca Guzzi
FMFederico Moretti
Federico Moretti
GCGiuseppe Carrà
Giuseppe Carrà

3 July 2025 in The Lancet Digital Health
Verified
Journal Article
Open access
Cristina CrocamoCristina Crocamo
Cristina Crocamo
DPDario Palpella
Dario Palpella
Daniele CavaleriDaniele Cavaleri
Daniele Cavaleri
CNChristian Nasti
Christian Nasti
SPSusanna Piacenti
Susanna Piacenti
GCGiuseppe Carrà
Giuseppe Carrà
Digital health interventions (DHIs) show promise for the treatment of mental health disorders. However, existing meta-analytical research is methodologically heterogeneous, with studies including a mix of clinical, non-clinical, and transdiagnostic populations, hindering a comprehensive understanding of DHI effectiveness. Thus, we conducted an umbrella review of meta-analyses of randomised controlled trials investigating the effectiveness of DHIs for specific mental health disorders and evaluating the quality of evidence. We searched three public electronic databases from inception to February, 2024 and included 16 studies. DHIs were effective compared with active interventions for schizophrenia spectrum disorders, major depressive disorder, social anxiety disorder, and panic disorder. Notable treatment effects compared with a waiting list were also observed for specific phobias, generalised anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and bulimia nervosa. Certainty of evidence was rated as very low or low in most cases, except for generalised anxiety disorder-related outcomes, which showed a moderate rating. To integrate DHIs into clinical practice, further high-quality studies with clearly defined target populations and robust comparators are needed.